18F-labeled FP-CIT PET Findings in a series of cirrhotic patients with parkinsonism
Objective: Our object is to evaluate the cirrhotic patients with parkinsonism using the presynaptic dopamine transporter (DAT) positron emission tomography (PET) imaging for dopaminergic deficit.…Tonsillectomy and risk of Parkinson’s disease: A Danish nationwide population-based cohort study
Objective: To our knowledge, no studies have examined whether the lymphoid tissue of the tonsils are involved PD, or whether tonsillectomy modifies the risk of PD.…Emergence of Non-motor Fluctuations with Reference to Motor Fluctuations in Parkinson’s Disease
Objective: To examine the timing of emergence of non-motor fluctuations (NMF) with reference to motor fluctuations (MF) in Parkinson’s Disease (PD). Background: NMF and MF…Speech and voice response to levodopa in late-stage Parkinson’s Disease patients: report from an acute levodopa challenge
Objective: to assess the change of speech and voice after an acute L-dopa challenge in late-stage Parkinson’s disease (LSPD). Background: PD patients are classically affected…Cognitive Impairment in MSA Patients from the Catalan Multiple System Atrophy Registry (CMSAR)
Objective: To assess the cognitive function and its demographic and clinical correlates in MSA patients included in the Catalan Multiple System Atrophy-Registry (CMSAR). Background: Cognitive…Dynamic Instability and Stride Width in Parkinsonism
Objective: To compare differences in local dynamic stability (LDS) and its association with stride width in individuals with idiopathic Parkinson’s Disease (iPD), individuals with frontal…Creutzfeldt-Jakob Disease with Corticobasal Syndrome-Like Onset: Case report
Objective: We present a 56-year-old man patient who diagnosed CJD with CBS-like onset. Background: Creutzfeldt-Jakob disease (CJD) is an untreatable rare human prion disease characterized…Management of parkinsonism in primary care.
Objective: To assess the use of inappropriate drugs among patients with parkinsonism in primary care. As secondary objectives, we planned to identify those clinical factors…Deep Brain Stimulation for Parkinson Disease before L-dopa treatment: experience in three cases.
Objective: The goal of these case series is to investigate the possibility of deep brain stimulation (DBS) prior to L-dopa treatment in young Parkinsson…Preoperative slowing of EEG and neurocognitive changes following subthalamic nucleus deep brain stimulation in Parkinson’s disease
Objective: We evaluated preoperative electroencephalography (EEG) as predictive markers for changes of neurocognitive functions following subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease (PD). …
- « Previous Page
- 1
- …
- 313
- 314
- 315
- 316
- 317
- …
- 405
- Next Page »
